Co-Diagnostics, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-6.3M | $-9.1M | $-25.7M | $-5.9M | $-7.7M | $-7.5M | $-11.0M | $-9.7M |
| Depreciation & Amortization | $201.8K | $255.4K | $267.6K | $267.4K | $291.4K | $280.4K | $357.1K | $351.2K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $213.8K | $219.1K | $292.0K | $500.6K | $580.3K | $875.2K | $1.3M | $1.0M |
| Net Cash from Operating Activities | $-7.2M | $-7.8M | $-6.2M | $-5.9M | $-8.3M | $-8.7M | $-8.2M | $-7.2M |
| Investing Activities | ||||||||
| Capital Expenditures | $18.3K | $142.0K | $132.0K | $75.1K | $401.1K | $91.9K | $73.0K | $174.4K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-168.3K | $-142.0K | $-329.4K | $2.2M | $17.1M | $7.4M | $266.0K | $4.2M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $2.7M | $4.3M | $7.0M | $4.1M | $429.0K | $354.7K | — | — |
| Net Change in Cash | $-4.6M | $-3.7M | $440.7K | $328.8K | $9.2M | $-1.0M | $-7.9M | $-3.1M |
| Free Cash Flow | $-7.2M | $-8.0M | $-6.3M | $-6.0M | $-8.7M | $-8.8M | $-8.3M | $-7.4M |